NEW YORK, Oct. 18 – Incyte Genomics and Medarex said Thursday they would work together to develop and commercialize human antibody therapeutics.

Under the terms of the deal, Medarex and Incyte will share the preclinical and clinical development costs associated with developing antibody products. The two companies said they would also jointly sell and distribute products resulting from the collaboration.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Vox explores a proposal to institute a lottery system to award grant funds.

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.